Nicklas Järvelä Johansen
4PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 13, 2023
The potential of colchicine for lowering the risk of cardiovascular events in type 1 diabetes.Nicklas Järvelä Johansen, Filip Krag Knop
|Oct 07, 2021
Effects of short-acting exenatide added three times daily to insulin therapy on bone metabolism in type 1 diabetes.Nicklas J Johansen, Thomas F Dejgaard, Asger Lund
|Jun 17, 2020
Effect of short-acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double-blind placebo-controlled trial.Nicklas J Johansen, Thomas F Dejgaard, Asger Lund
|Jun 29, 2018
Protocol for Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetes Cases (The MAG1C trial): a randomised, double-blinded, placebo-controlled trial.Nicklas Järvelä Johansen, Thomas Fremming Dejgaard, Asger Lund
Pageof 1
